Naropin Ropivacaine 0.5% Recall
Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fre
Updated July 16, 2026
Fresenius Kabi is recalling Naropin (ropivacaine hydrochloride injection) 0.5%, 20 mL single-dose vials because hair was found in some products. Use of contaminated injection solution can introduce foreign material into the body, posing a serious risk.
Is the Fresenius Kabi USA, LLC recalled? Yes. This product was recalled by FDA on July 16, 2026. Details below.
What is recalled
Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five 20 mL Single-Dose Vials, NDC Tray: 63323-286-23, NDC Vial: 63323-286-05, manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL.
Am I affected
You are affected if you have Naropin 0.5% single-dose vials with NDC Tray 63323-286-23 or NDC Vial 63323-286-05. Check the label on the vial for these numbers.
What to do right now
Stop using this product immediately. Contact Fresenius Kabi USA, LLC or your healthcare provider with questions about affected vials or the injection you received.
The hazard
Presence of Particulate Matter: Hair was found in products
Brands affected
- Source
- FDA
- Category
- Drugs & Medications
- Recall ID
- fda-D-0727-2026
- Classification
- Class II
- Recalled
- July 16, 2026
Get free recall alerts
New Drugs & Medications recalls, the moment they post.
Free forever. Unsubscribe anytime. We never sell your data.
More Drugs & Medications recalls
Rohto Cooling Eye Drops Recall
Rohto Cooling Eye Drops Max Strength (0.4 FL OZ / 13 mL bottles) has been recalled because the manufacturer cannot confirm the product is sterile. Using …
Rohto-Mentholatum (Vietnam) Co., Ltd.
Rohto Cooling Eye Drops Recall
Rohto Cooling Eye Drops Cool Relief has been recalled because the manufacturer cannot guarantee the product is sterile. Use of non-sterile eye drops can lead to …
Rohto-Mentholatum (Vietnam) Co., Ltd.
Major Pharmaceuticals Levothyroxine Recall
Major Pharmaceuticals is recalling Levothyroxine Sodium 88 mcg tablets because they are subpotent, meaning they contain less active ingredient than labeled. …
Major Pharmaceuticals